Figure 4.
Overall and progression-free survival based on presence (n = 13) or absence (n = 31) of extramedullary manifestation prior to CD34-selected HSCT.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.